Page last updated: 2024-08-21

pyrazines and Asthenia

pyrazines has been researched along with Asthenia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, K; Laubach, JP; Mitsiades, C; Richardson, PG; Schlossman, RL	1
Anderson, K; Hideshima, T; Mitsiades, C; Richardson, PG	1
Colson, K; Doss, DS; Swift, R; Tariman, J; Thomas, TE	1
Carbonell, AL; del Giglio, A; Manhani, AR; Mitteldorf, CA; Weinschenker, P	1

Reviews

2 review(s) available for pyrazines and Asthenia

Article	Year
Proteasome inhibition in hematologic malignancies. Annals of medicine, 2004, Volume: 36, Issue:4 Topics: Asthenia; Boronic Acids; Bortezomib; Cysteine Endopeptidases; Diarrhea; Hematologic Neoplasms; Humans; Multienzyme Complexes; Nausea; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Survival Analysis; Treatment Outcome	2004
Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications. Clinical journal of oncology nursing, 2004, Volume: 8, Issue:5 Topics: Anemia; Antineoplastic Agents; Asthenia; Boronic Acids; Bortezomib; Clinical Trials as Topic; Drug Approval; Drug Monitoring; Gastrointestinal Diseases; Humans; Hypotension; Multiple Myeloma; Neutropenia; Nurse's Role; Oncology Nursing; Patient Care Planning; Patient Education as Topic; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Quality of Life; Thrombocytopenia; Water-Electrolyte Imbalance	2004

Article

Year

Proteasome inhibition in hematologic malignancies.

Annals of medicine, 2004, Volume: 36, Issue:4

Topics: Asthenia; Boronic Acids; Bortezomib; Cysteine Endopeptidases; Diarrhea; Hematologic Neoplasms; Humans; Multienzyme Complexes; Nausea; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Survival Analysis; Treatment Outcome

2004

Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications.

Clinical journal of oncology nursing, 2004, Volume: 8, Issue:5

Topics: Anemia; Antineoplastic Agents; Asthenia; Boronic Acids; Bortezomib; Clinical Trials as Topic; Drug Approval; Drug Monitoring; Gastrointestinal Diseases; Humans; Hypotension; Multiple Myeloma; Neutropenia; Nurse's Role; Oncology Nursing; Patient Care Planning; Patient Education as Topic; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Quality of Life; Thrombocytopenia; Water-Electrolyte Imbalance

2004

Other Studies

3 other study(ies) available for pyrazines and Asthenia

Article	Year
Complications of multiple myeloma therapy, part 1: risk reduction and management of peripheral neuropathy and asthenia. Journal of the National Comprehensive Cancer Network : JNCCN, 2010, Volume: 8 Suppl 1 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Asthenia; Boronic Acids; Bortezomib; Humans; Multiple Myeloma; Peripheral Nervous System Diseases; Prognosis; Pyrazines; Risk Management; Risk Reduction Behavior; Thalidomide	2010
Bortezomib (velcade) for multiple myeloma. The Medical letter on drugs and therapeutics, 2003, Jul-21, Volume: 45, Issue:1161 Topics: Antineoplastic Agents; Asthenia; Boronic Acids; Bortezomib; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Economics, Pharmaceutical; Fees, Pharmaceutical; Humans; Multiple Myeloma; Nausea; Pyrazines	2003
Hepatic plasmacytosis as a manifestation of relapse in multiple myeloma treated with thalidomide. Southern medical journal, 2005, Volume: 98, Issue:2 Topics: Antineoplastic Agents; Asthenia; Biopsy; Bone Marrow Cells; Boronic Acids; Bortezomib; Female; Humans; Immunosuppressive Agents; Liver; Liver Neoplasms; Middle Aged; Multiple Myeloma; Plasma Cells; Plasmacytoma; Pyrazines; Recurrence; Thalidomide	2005